{"created_at":"Wed Jan 07 22:41:13 +0000 2015","id":552958160814612481,"id_str":"552958160814612481","text":"$CGRW Stock Forum Updated Wednesday, January 7, 2015 5:11:21 PM $UUP $SDRL $AMGN $GM http:\/\/t.co\/Zh4CPeSDjV","source":"\u003ca href=\"http:\/\/dlvr.it\" rel=\"nofollow\"\u003edlvr.it\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2197054086,"id_str":"2197054086","name":"IH News Desk","screen_name":"IHNewsDesk","location":"","url":null,"description":"Investors Hangout News Desk","protected":false,"verified":false,"followers_count":333,"friends_count":506,"listed_count":11,"favourites_count":0,"statuses_count":54947,"created_at":"Sat Nov 16 03:54:44 +0000 2013","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"131516","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme14\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme14\/bg.gif","profile_background_tile":true,"profile_link_color":"009999","profile_sidebar_border_color":"EEEEEE","profile_sidebar_fill_color":"EFEFEF","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000745601641\/0aa5ed786102f499384a344e7ce49e13_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000745601641\/0aa5ed786102f499384a344e7ce49e13_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/Zh4CPeSDjV","expanded_url":"http:\/\/bit.ly\/1HPnw7V","display_url":"bit.ly\/1HPnw7V","indices":[85,107]}],"user_mentions":[],"symbols":[{"text":"CGRW","indices":[0,5]},{"text":"UUP","indices":[64,68]},{"text":"SDRL","indices":[69,74]},{"text":"AMGN","indices":[75,80]},{"text":"GM","indices":[81,84]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1420670473661"}
{"created_at":"Wed Jan 07 15:16:47 +0000 2015","id":552846315508727809,"id_str":"552846315508727809","text":"$NVS Sandoz Sigrid Balser:We have quite some extensive postmarketing experience w\/ #Zarzio (European name for #Zarxio) \n #FDA #ODAC $AMGN","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":593813785,"id_str":"593813785","name":"Donna Young","screen_name":"ScripDonnaDC","location":"Washington","url":"http:\/\/scripintelligence.com\/capitolcapsule\/","description":"Washington Editor for Scrip Intelligence","protected":false,"verified":false,"followers_count":2433,"friends_count":1633,"listed_count":114,"favourites_count":62,"statuses_count":19729,"created_at":"Tue May 29 15:45:45 +0000 2012","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/828264930\/6cd70d5efa13824b51e8f8dbd73a36c3.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/828264930\/6cd70d5efa13824b51e8f8dbd73a36c3.jpeg","profile_background_tile":true,"profile_link_color":"0084B4","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/474939099648778240\/Ug76s07w_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/474939099648778240\/Ug76s07w_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/593813785\/1402071031","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"Zarzio","indices":[83,90]},{"text":"Zarxio","indices":[110,117]},{"text":"FDA","indices":[121,125]},{"text":"ODAC","indices":[126,131]}],"trends":[],"urls":[],"user_mentions":[],"symbols":[{"text":"NVS","indices":[0,4]},{"text":"AMGN","indices":[132,137]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1420643807662"}
{"created_at":"Wed Jan 07 21:56:05 +0000 2015","id":552946802627182593,"id_str":"552946802627182593","text":"RT @FierceBiotech: Novartis clears an FDA hurdle with its pioneering biosimilar. http:\/\/t.co\/5BLeneykHZ by @DamianFierce $NVS $AMGN","source":"\u003ca href=\"http:\/\/twitter.com\/download\/iphone\" rel=\"nofollow\"\u003eTwitter for iPhone\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":222812107,"id_str":"222812107","name":"Ronald J. Perez, PhD","screen_name":"rjperez_phd","location":"New York, NY","url":"http:\/\/www.linkedin.com\/in\/rjperez","description":"Scientist | Pharmacologist | Bio-IT Aficionado | Pharmaceutical Consultant","protected":false,"verified":false,"followers_count":444,"friends_count":1947,"listed_count":16,"favourites_count":246,"statuses_count":1500,"created_at":"Sat Dec 04 14:45:24 +0000 2010","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"FFFFFF","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/728368317\/1ef8783eb696a383b97b4231c0012ee3.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/728368317\/1ef8783eb696a383b97b4231c0012ee3.jpeg","profile_background_tile":false,"profile_link_color":"47484D","profile_sidebar_border_color":"BABAB2","profile_sidebar_fill_color":"BABAB2","profile_text_color":"2891E2","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/463705400756285440\/YN29JRxi_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/463705400756285440\/YN29JRxi_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/222812107\/1403201615","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Wed Jan 07 21:55:52 +0000 2015","id":552946748789112832,"id_str":"552946748789112832","text":"Novartis clears an FDA hurdle with its pioneering biosimilar. http:\/\/t.co\/5BLeneykHZ by @DamianFierce $NVS $AMGN","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294197,"id_str":"18294197","name":"FierceBiotech","screen_name":"FierceBiotech","location":"Washington, DC","url":"http:\/\/FierceBiotech.com","description":"Tweets by the Fierce Life Sciences editorial team. Subscribe to our daily email newsletter at http:\/\/www.fiercebiotech.com\/offer\/signup","protected":false,"verified":false,"followers_count":37523,"friends_count":466,"listed_count":1194,"favourites_count":7,"statuses_count":15213,"created_at":"Sun Dec 21 22:21:58 +0000 2008","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"15184C","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"DB5E1F","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"EBEFC3","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":1,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/5BLeneykHZ","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/novartis-clears-fda-hurdle-pioneering-biosimilar\/2015-01-07","display_url":"fiercebiotech.com\/story\/novartis\u2026","indices":[62,84]}],"user_mentions":[{"screen_name":"DamianFierce","name":"Damian Garde","id":529704495,"id_str":"529704495","indices":[88,101]}],"symbols":[{"text":"NVS","indices":[102,106]},{"text":"AMGN","indices":[107,112]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/5BLeneykHZ","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/novartis-clears-fda-hurdle-pioneering-biosimilar\/2015-01-07","display_url":"fiercebiotech.com\/story\/novartis\u2026","indices":[81,103]}],"user_mentions":[{"screen_name":"FierceBiotech","name":"FierceBiotech","id":18294197,"id_str":"18294197","indices":[3,17]},{"screen_name":"DamianFierce","name":"Damian Garde","id":529704495,"id_str":"529704495","indices":[107,120]}],"symbols":[{"text":"NVS","indices":[121,125]},{"text":"AMGN","indices":[126,131]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1420667765658"}
{"created_at":"Wed Jan 07 13:26:04 +0000 2015","id":552818452726296576,"id_str":"552818452726296576","text":"#FDA's Christl: #biosimilars app from $NVS Sandoz requests biosimilar but not interchangeable\n#ODAC #Zarxio $AMGN #pharma #biotech","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":593813785,"id_str":"593813785","name":"Donna Young","screen_name":"ScripDonnaDC","location":"Washington","url":"http:\/\/scripintelligence.com\/capitolcapsule\/","description":"Washington Editor for Scrip Intelligence","protected":false,"verified":false,"followers_count":2428,"friends_count":1633,"listed_count":114,"favourites_count":62,"statuses_count":19699,"created_at":"Tue May 29 15:45:45 +0000 2012","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/828264930\/6cd70d5efa13824b51e8f8dbd73a36c3.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/828264930\/6cd70d5efa13824b51e8f8dbd73a36c3.jpeg","profile_background_tile":true,"profile_link_color":"0084B4","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/474939099648778240\/Ug76s07w_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/474939099648778240\/Ug76s07w_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/593813785\/1402071031","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"FDA","indices":[0,4]},{"text":"biosimilars","indices":[16,28]},{"text":"ODAC","indices":[94,99]},{"text":"Zarxio","indices":[100,107]},{"text":"pharma","indices":[114,121]},{"text":"biotech","indices":[122,130]}],"trends":[],"urls":[],"user_mentions":[],"symbols":[{"text":"NVS","indices":[38,42]},{"text":"AMGN","indices":[108,113]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1420637164657"}
